[Prevalence of anti-LAV/HTLV III antibodies in groups at risk of infection and in donors blood in the province of Catania]. 1987

L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
Istituto di Igiene e Medicina Preventiva, Università degli Studi di Catania.

The prevalence of anti-LAV/HTLV III antibodies in serum samples of individuals at high risk for AIDS and of healthy individuals living in the province of Catania is reported. Serum samples were collected over the period 1983-86 from 220 drug addicts adults, 339 from multitransfused thalassemia patients, 71 from hemophiliacs, 22 from subjects of the hospital staff who had had contacts with positive subjects, 9 from family contacts of positive multitransfused thalassemics and 7270 from blood donors. Prevalence of antibodies among drug addicts was 14% and a positive subject was found as early as 1983. This result suggested that LAV/HTLV III was already present in Catania at that year. Among the thalassemics and the hemophiliacs the prevalence was 2.3% and 21% respectively. No positive subject was found among hospital staff nor among family contacts of positive thalassemic subjects. Three positive cases have been found among the blood donors and even though these are drug addicts, it is important to underline the necessity of a regular screening of the blood units to prevent LAV/HTLV III diffusion.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias

Related Publications

L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
January 1985, La Ricerca in clinica e in laboratorio,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
January 1987, Antibiotics and chemotherapy,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
April 1986, Medicina clinica,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
June 1986, Medicina clinica,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
January 1986, Rivista di emoterapia ed immunoematologia,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
June 1986, Revue francaise de transfusion et immuno-hematologie,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
January 1987, Medicina clinica,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
January 1987, Haematology and blood transfusion,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
April 1986, JAMA,
L Mauro, and M Ciccia, and M A Romeo, and F Di Gregorio, and S Sciacca, and S Maccarrone
January 1986, Bollettino dell'Istituto sieroterapico milanese,
Copied contents to your clipboard!